Fonar Corporation announced its financial results for the third quarter of fiscal 2025, revealing a 6% increase in Total Revenues-Net to $27.2 million for the quarter ended March 31, 2025, compared to $25.7 million in the same quarter of the previous year. Net Income saw a notable rise of 25%, reaching $3.1 million for the quarter, up from $2.48 million the year before. Additionally, Diluted Net Income Per Common Share Available to Common Stockholders increased by 37% to $0.37 per share from $0.27 per share in the prior year's quarter. Income from Operations experienced a slight decrease of 2%, totaling $3.7 million compared to $3.8 million in the corresponding quarter of the previous year. The company also reported a decrease in Total Cash, Cash Equivalents, and Short-Term Investments by 4%, standing at $54.4 million as of March 31, 2025, down from $56.67 million as of June 30, 2024. Fonar's diagnostic imaging management subsidiary, Health Management Company of America $(HMCA.UK)$, set a new company record by completing 54,612 MRI scans in the third quarter, marking a 2.8% increase from the previous quarter and a 3.4% increase compared to the same quarter in fiscal 2024. Over the nine-month period, HMCA achieved a record 160,780 MRI scans, a 3.9% rise from 154,790 scans in the corresponding period of the previous year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.